American Oncology Network, Inc. (Nasdaq: AONC) filed a Form 15-15D with the SEC on January 2, 2025, signaling the termination of its reporting obligations under Section 15(d) of the Securities Exchange Act. The company reached public markets through a business combination with Digital Transformation Opportunities Corp., a healthcare-focused blank-check vehicle sponsored by DTOC Management LLC that completed its IPO in 2021. American Oncology Network operates as a physician-led oncology care network delivering cancer treatment services across the United States. The deregistration filing represents a notable post-merger milestone for the combined company. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on AONC and hundreds of other SPAC transactions.